Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
LIXT —
LIXTE BIOTECHNOLOGY HLDGS IN
CUSIP: 539319301 · Held by 2 superinvestors · Combined value: $477,860
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $422,475 | 107,500 | ADD | +34,350 |
| 2 | Ken Griffin | 0.0% | $55,385 | 14,093 | NEW BUY | +14,093 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | NEW BUY | +14,093 | New |
| Jim Simons | ADD | +34,350 | +47.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | NEW BUY | +73,150 | New |
Who Owns LIXT? Superinvestor Holdings
LIXTE BIOTECHNOLOGY HLDGS IN is held by 2 tracked superinvestors, with a combined position value of $477,860 . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.